Volume 5, Number 3—June 1999
Bacterial Vaccines and Serotype Replacement: Lessons from Haemophilus influenzae and Prospects for Streptococcus pneumoniae
- Centers for Disease Control and Prevention. Prevention of pneumococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep. 1997;46:RR8.
- Centers for Disease Control and Prevention. Progress toward elimination of Haemophilus influenzae type b disease among infants and children—United States, 1987-1995. MMWR Morb Mortal Wkly Rep. 1996;45:901–6.
- Booy R, Kroll JS. Is Haemophilus influenzae finished? J Antimicrob Chemother. 1997;40:149–53.
- Dagan R, Melamed R, Muallem M, Piglansky L, Greenberg D, Abramson O, Reduction of nasopharyngeal carriage of pneumococci during the second year of life by a heptavalent conjugate pneumococcal vaccine. J Infect Dis. 1996;174:1271–8.
- Obaro SK, Adegbola RA, Banya WAS, Greenwood BM. Carriage of pneumococci after pneumococcal vaccination. Lancet. 1996;348:271–2.
- Mbelle N, Wasas A, Huebner R, Kimura A, Chang I, Klugman K. Immunogenicity and impact on carriage of 9-valent pneumococcal conjugate vaccine given to infants in Soweto, South Africa. Proceedings from the Interscience Conference on Antimicrobial Agents and Chemotherapy; September 28-October 1, 1997; Toronto, Canada. LB-12, p. 13.
- Dagan R, Givon N, Yagupsky P, Porat N, Janco J, Chang I, Effect of a 9-valent pneumococcal vaccine conjugated to CRM197 (PncCRM9) on nasopharyngeal (NP) carriage of vaccine type and non-vaccine type S. pneumoniae (Pnc) strains among day-care-center (DCC) attendees. Proceedings from the 38th Interscience Conference on Antimicrobial Agents and Chemotherapy; September 24-27, 1998; San Diego, California. G52.
- Black S, Shinefield H, Ray P, Lewis E, Fireman B; The Kaiser Permanente Vaccine Study Group. Efficacy of heptavalent conjugate pneumococcal vaccine (Wyeth Lederle) in 37,000 infants and children: results of the Northern California Kaiser Permanente Efficacy Trial. Proceedings from the 38th Interscience Conference on Antimicrobial Agents and Chemotherapy; September 24-27, 1998; San Diego, California. LB-9.
- Barbour ML. Conjugate vaccines and the carriage of Haemophilus influenzae type b. Emerg Infect Dis. 1996;2:176–82.
- Moxon ER. The carrier state: Haemophilus influenzae. J Antimicrob Chemother 1986;18 Suppl A:17-24.
- Austrian R. Some aspects of the pneumococcal carrier state. J Antimicrob Chemother 1986;18 Suppl A:35-45.
- Lipsitch M, Moxon ER. Virulence and transmissibility of pathogens: what is the relationship? Trends Microbiol. 1997;5:31–7.
- Topley WWC. The spread of bacterial infection. Lancet 1919;July 5:1-5.
- Levin BR, Bull JJ. Short-sighted evolution and the virulence of pathogenic microbes. Trends Microbiol. 1994;2:76–81.
- Barbour ML, Mayon-White RT, Coles C, Crook DWM, Moxon ER. The impact of conjugate vaccine on carriage of Haemophilus influenzae type b. J Infect Dis. 1995;171:93–8.
- Adams WG, Deaver KA, Cochi SL, Plikaytis BD, Zell ER, Broome CV, Decline of childhood Haemophilus influenzae type b (Hib) disease in the Hib vaccine era. JAMA. 1993;269:221–6.
- Wenger JD, Pierce R, Deaver K, Franklin R, Bosley G, Pigott N, Invasive Haemophilus influenzae disease: a population-based evaluation of the role of capsular polysaccharide serotype. J Infect Dis. 1992;165(Suppl 1):S34–5.
- Farley MM, Stephens DS, Brachman PS Jr. Invasive Haemophilus influenzae disease in adults: a prospective, population-based surveillance. Ann Intern Med. 1992;116:806–12.
- Nitta DM, Jackson MA, Burry VF, Olson LC. Invasive Haemophilus influenzae type f disease. Pediatr Infect Dis J. 1995;14:157–60.
- Greene GR. Meningitis due to Haemophilus influenzae other than type b: case report and review. Pediatrics. 1978;62:1021–5.
- Takala AK, Eskola J, Leinonen M, Kayhty H, Nissinen A, Pekkanen E, Reduction of oropharyngeal carriage of Haemophilus influenzae type b (Hib) in children immunized with an Hib conjugate vaccine. J Infect Dis. 1991;164:982–6.
- Booy R, Heath P, Willocks L, Mayon-White D, Slack M, Moxon R. Invasive pneumococcal infections in children. Lancet. 1995;345:1245–6.
- Urwin G, Krohn JA, Deaver-Robinson K, Wenger JD, Farley MM, Group HIS. Invasive disease due to Haemophilus influenzae serotype f: clinical and epidemiological characteristics in the H. influenzae serotype b vaccine era. Clin Infect Dis. 1996;22:1069–76.
- Baer M, Vuento R, Vesikari T. Increase in bacteraemic pneumococcal infections in children. Lancet. 1995;345:661.
- Schuchat A, Robinson K, Wenger JD, Harrison LH, Farley M, Reingold AL, Bacterial meningitis in the United States in 1995. N Engl J Med. 1997;337:970–6.
- Anderson RM, May RM. Infectious diseases of humans: dynamics and control. Oxford: Oxford University Press; 1991.
- Hodges RG, MacLeod CM, Bernhard WG. Epidemic pneumococcal pneumonia. III. Carrier studies. Am J Hyg. 1946;44:207–30.
- Pradier C, Dunais B, Carsenti-Etesse H, Largillier R, Bernard E, Dellamonica P. Nasopharyngeal carriage of penicillin-resistant Streptococcus pneumoniae (PRSP): prevalence and incidence in three children's day-care centres in Nice, France, from 1994 to 1995. Proceedings from the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy; September 15-18, 1996; New Orleans, Louisiana. C56.
- Reichler MR, Allphin AA, Breiman RF, Schreiber JR, Arnold JE, McDougal LK, The spread of multiply resistant Streptococcus pneumoniae at a day care center in Ohio. J Infect Dis. 1992;166:1346–53.
- Sanders CC, Sanders WE Jr, Harrowe DJ. Bacterial interference: effects of oral antibiotics on the normal throat flora and its ability to interfere with group A streptococci. Infect Immun. 1976;13:808–12.
- Johanson WG Jr, Blackstock R, Pierce AK, Sanford JP. The role of bacterial antagonism in pneumococcal colonization of the human pharynx. J Lab Clin Med. 1970;75:946–52.
- Venezia RA, Robertson RG. Bactericidal substance produced by Haemophilus influenzae type b. Can J Microbiol. 1975;21:1587–94.
- Lipsitch M. Vaccination against colonizing bacteria with multiple serotypes. Proc Natl Acad Sci U S A. 1997;94:6571–6.
- Sutton A, Schneerson R, Kendall-Morris S, Robbins JB. Differential complement resistance mediates virulence of Haemophilus influenzae type b. Infect Immun. 1982;35:95–104.
- Smith T, Lehmann D, Montgomery J, Gratten M, Riley ID, Alpers MP. Acquisition and invasiveness of different serotypes of Streptococcus pneumoniae in young children. Epidemiol Infect. 1993;111:27–39.
- Ewald PW. Vaccines as evolutionary tools: the virulence-antigen strategy. In: Kaufmann SHE, editor. Concepts in vaccine development. Berlin: Walter de Gruyter; 1996.
- Moxon ER, Vaughn KA. The type b capsular polysaccharide as a virulence determinant of Haemophilus influenzae: studies using clinical isolates and laboratory transformants. J Infect Dis. 1981;14:517–24.
- Kelly T, Dillard JP, Yother J. Effect of genetic switching of capsular type on virulence of Streptococcus pneumoniae. Infect Immun. 1994;62:1813–9.
- Barnes DM, Whittier S, Gilligan PH, Soares S, Tomasz A, Henderson FW. Transmission of multidrug-resistant serotype 23F Streptococcus pneumoniae in group day care: evidence suggesting capsular transformation of the resistant strain in vivo. J Infect Dis. 1995;171:890–6.
- Takala AK, Vuopio-Varkila J, Tarkka E, Leinonen M, Musser JM. Subtyping of common pediatric pneumococcal serotypes from invasive disease and pharyngeal carriage in Finland. J Infect Dis. 1996;173:128–35.
- Gratten M, Montgomery J, Gerega G, Gratten H, Siwi H, Poli A, Multiple colonization of the upper respiratory tract of Papua New Guinea children with Haemophilus influenzae and Streptococcus pneumoniae. Southeast Asian J Trop Med Public Health. 1989;20:501–9.
- Gilks WR, Spiegelhalter DJ. A language and program for complex Bayesian modeling. Statistician. 1994;43:169–78.
- Spiegelhalter DJ, Thomas A, Best NG, Gilks WR. BUGS: Bayesian inference using Gibbs sampling. Version 0.50. Cambridge: MRC Biostatistics Unit; 1995.
- Musher DM, Groover JE, Reichler MR, Riedo FX, Schwarz B, Watson DA, Emergence of antibody to capsular polysaccharides of Streptococcus pneumoniae during outbreaks of pneumonia: association with nasopharyngeal colonization. Clin Infect Dis. 1997;24:441–6.
- Dagan R, Melamed R, Muallem M, Piglansky L, Yagupsky P. Nasopharyngeal colonization in southern Israel with antibiotic-resistant pneumococci during the first 2 years of life: relation to serotypes likely to be included in pneumococcal conjugate vaccines. J Infect Dis. 1996;174:1352–5.
- Butler JC. Epidemiology of pneumococcal serotypes and conjugate vaccine formulations. Microb Drug Resist. 1997;3:125–9.
- Paton JC. Novel pneumococcal surface proteins: role in virulence and vaccine potential. Trends Microbiol. 1998;6:85–7.
Page created: December 10, 2010
Page updated: December 10, 2010
Page reviewed: December 10, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.